Replies to post #11247 on GT Biopharma Inc (GTBP)

[SmallCapStockGuy]

"Since neurological diseases are disorders of the brain, spinal cord and nerves throughout the body, Dr. Chase’s background could be pivotal when it comes to the further development of GT Biopharma (OXISD)’s GTP-004. This is a treatment for myasthenia gravis, which is a rare muscular disease triggered by antibodies that attack certain parts of muscles."

From the Huffington article today: http://www.huffingtonpost.com/entry/another-big-name-in-biotech-heads-to-gt-biopharma-inc_us_59c11277e4b082fd4205b9af